Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Document and Entity Information

Document and Entity Information
12 Months Ended
Dec. 31, 2017
Document And Entity Information  
Entity Registrant Name Can-Fite BioPharma Ltd.
Entity Central Index Key 0001536196
Trading Symbol canf
Amendment Flag false
Current Fiscal Year End Date --12-31
Document Type 6-K
Document Fiscal Period Focus FY
Document Period End Date Dec. 31, 2017
Document Fiscal Year Focus 2017
Entity Filer Category Non-accelerated Filer
Entity Common Stock, Shares Outstanding 33,295,618